Literature DB >> 13959034

An acquired type of refractoriness to graft-versus-host reaction in adult F1 hybrid mice.

M FOX, J G HOWARD.   

Abstract

Entities:  

Keywords:  SPLEEN; TRANSPLANTATION

Mesh:

Year:  1963        PMID: 13959034     DOI: 10.1097/00007890-196301010-00002

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  8 in total

1.  Analysis of immunosuppression generated by the graft-versus-host reaction. I. A suppressor T-cell component studied in vivo.

Authors:  F L Shand
Journal:  Immunology       Date:  1975-12       Impact factor: 7.397

2.  DEFICIENT GROWTH OF C57BL MARROW CELLS TRANSPLANTED IN F1 HYBRID MICE. ASSOCIATION WITH THE HISTOCOMPATIBILITY-2 LOCUS.

Authors:  G CUDKOWICZ; J H STIMPFLING
Journal:  Immunology       Date:  1964-05       Impact factor: 7.397

3.  The effect of cyclophosphamide and methotrexate on the 'field effect' or unresponsiveness observed in the rat and mouse GvHR.

Authors:  L Levy
Journal:  Agents Actions       Date:  1975-08

4.  Reduced sensitivity of F-1 hybrid rats to re-challenge with parental strain spleen cells.

Authors:  E O Field; J E Gibbs
Journal:  Clin Exp Immunol       Date:  1966-04       Impact factor: 4.330

5.  Selective stimulation of a cellular immune response by methotrexate.

Authors:  L Levy; M W Whitehouse
Journal:  Agents Actions       Date:  1974-04

6.  Accelerated immunological maturation in the chick.

Authors:  R A McBride; L W Coppleson; N W Nisbet; M Simonsen; A Skowron-Cendrzak; H L Wigzell
Journal:  Immunology       Date:  1966-01       Impact factor: 7.397

7.  The local graft versus host reaction in the rat as a tool for drug mechanism studies.

Authors:  F J Beck; L Levy; M W Whitehouse
Journal:  Br J Pharmacol       Date:  1973-10       Impact factor: 8.739

8.  Analysis of graft-versus-host disease in Syrian hamsters. IV. The refractory state and immunologic competence.

Authors:  J W Streilein
Journal:  J Exp Med       Date:  1972-03-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.